:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Tzeng, Yen-Dun Tony, Chiang, An-Jen, Li, Chia-Jung
Format:	Artículo científico
Language:	en
Published:	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026
Online Access:	https://pubmed.ncbi.nlm.nih.gov/41724057/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mitoxyperilysis links organelle positioning to inflammatory lysis: A new lens for pharmacotherapy design.
by: Tzeng, Yen-Dun Tony, et al.
Published: (2026)

Suppression of CDC42 potential in breast cancer tumor microenvironment by tumor necrosis factor inhibitors
by: Yi‐Yu Chou, et al.
Published: (2024)

Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking.
by: Tzeng, Yen-Dun Tony, et al.
Published: (2026)

ATP synthasome contributes to efficient energy flux in malignant breast cancer.
by: Tzeng, Yen-Dun Tony, et al.
Published: (2026)

Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
by: Angel Guan, et al.
Published: (2024)

NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy
by: Alaa Alsalloum, et al.
Published: (2024)

Narrative review of neoadjuvant therapy in patients with locally advanced colon cancer
by: Jen‐Pin Chuang, et al.
Published: (2024)

Targeting lysine methyltransferase 2C deficiency: New frontiers in breast cancer therapy and prognosis
by: Shuangmei Tong, et al.
Published: (2026)

hsa-lactylation-code
by: Aoshima, Keisuke
Published: (2025)

Effectiveness of a Structured Disaster Management Training Program on Nurses’ Disaster Readiness for Response to Emergencies and Disasters: A Randomized Controlled Trial
by: Chia-Huei Lin, et al.
Published: (2024)

TML‐6 targeting at regulation of autophagolysosomal machinery in neurons and microglia represents a novel drug for AD therapy
by: Ih‐Jen Su, et al.
Published: (2025)

Histone lactylation‐mediated up‐regulation of IGF2BP2 enhances ferroptosis resistance via Nrf2 in colorectal cancer
by: Jin‐Feng Zhu, et al.
Published: (2025)

Feedback regulation between histone H3 lysine 18 lactylation and TROP2‐mediated glycolysis drives metastatic progression of colorectal cancer
by: Weifeng Wang, et al.
Published: (2026)

Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
by: Daniel Reinhorn, et al.
Published: (2025)

DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy
by: Ze‐Wei Zhao, et al.
Published: (2025)

Alanyl‐tRNA synthetase AARS1: A novel lactate sensor and lactyltransferase mediating p53 lactylation and tumorigenesis
by: Qiqing Yang, et al.
Published: (2024)

Gut microbiome‐derived metabolites show promise in cancer research and therapy (2/2026)
by: Kangjie Yang, et al.
Published: (2026)

A low complexity contextual stacked ensemble-learning approach for pedestrian intent prediction
by: Chiang, Chia-Yen, et al.
Published: (2024)

Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.
by: Lin, Pei-Hsuan, et al.
Published: (2026)

Algae-derived polysaccharides and polysaccharide-based nanoparticles: A natural frontier in breast cancer therapy.
by: Cai, Jiaer, et al.
Published: (2025)

Wnt/beta‐catenin modulation: A promising frontier in chronic kidney disease management
by: Shubhangi Saxena, et al.
Published: (2024)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
by: Swastika Maitra, et al.
Published: (2024)

ERK autoinhibition mechanism informs a drug combination strategy
by: Clil Regev, et al.
Published: (2026)

Explaining the Family‐Centred Care of Young People With Depressive Disorders and Suicidal Ideations: A Grounded Theory Study
by: Fan‐Ko Sun, et al.
Published: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
by: Chia‐Ling Hsieh, et al.
Published: (2024)

Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
by: Jun He, et al.
Published: (2024)

The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway
by: Runqi Hong, et al.
Published: (2024)

The frontier and the development of Argentine Culture
by: Miller, Elbert E
Published: (1979)

Unlocking the multifaceted molecular functions and diverse disease implications of lactylation
by: Fengyang Jing, et al.
Published: (2024)

Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
by: Wei Gao, et al.
Published: (2024)

Targeting autophagy: A promising approach for the treatment of breast cancer brain metastases
by: Steffan T. Nawrocki, et al.
Published: (2024)

Targets of tumor microenvironment for potential drug development
by: Ling Zhang, et al.
Published: (2024)

Fidelity and quantum geometry approach to Dirac exceptional points in diamond nitrogen-vacancy centers
by: Ju, Chia-Yi, et al.
Published: (2026)

The histone lactylation of AIM2 influences the suppression of ferroptosis by ACSL4 through STAT5B and promotes the progression of lung cancer
by: Songze Wu, et al.
Published: (2025)

FOXM1/DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy
by: Teng Wei, et al.
Published: (2024)

Red blood cell derived nanocarrier drug delivery system: a promising strategy for tumor therapy (3/2024)
by: Xin Wang, et al.
Published: (2024)

Mitochondria‐derived vesicles: A promising and potential target for tumour therapy
by: Xueqiang Peng, et al.
Published: (2025)

Antiproliferative and apoptotic effects of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) in oral cancer cells are mediated by oxidative stress and ERK activation.
by: Chuang, Ya-Ting, et al.
Published: (2025)

Ensemble optimal control for managing drug resistance in cancer therapies
by: Scagliotti, Alessandro, et al.
Published: (2025)

Natural products and cancer: From drug discovery to prevention and therapy
by: Angelo A. Izzo, et al.
Published: (2025)